Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

POLY MEDICURE LTD. - 531768 - Outcome Of Board Meeting 04.11.2022

 Pursuant to Regulation 30 and 33 of SEBI (LODR) Regulations, 2015, We are pleased to inform the Stock Exchange that the Board of Directors at their meeting held today i.e. 04th November, 2022, at 232-B, 3RD Floor, Okhla Industrial Estate, Phase-III, New Delhi - 110020, approved the following businesses: a) Unaudited Financial Results (Consolidate & Standalone) for the Second quarter and half year ended on 30th September 2022. b) Any Other Item. The Meeting was started at 10.30 am and concluded on 12:15 pm.
05-11-2022
Bigul

POLY MEDICURE LTD. - 531768 - Unaudited Standalone & Consolidated Financial Results For The Quarter Ended 0N 30.09.2022 Adopted In Board Meeting Held On 04.11.2022

 Pursuant to Regulation 30 and 33 of SEBI (LODR) Regulations, 2015, We are pleased to inform the Stock Exchange that the Board of Directors at their meeting held today i.e. 04th November, 2022, at 232-B, 3RD Floor, Okhla Industrial Estate, Phase-III, New Delhi - 110020, approved the following businesses: a) Unaudited Financial Results (Consolidate & Standalone) for the Second quarter and half year ended on 30th September 2022.
04-11-2022
Bigul

POLY MEDICURE LTD. - 531768 - Board Meeting Outcome for Outcome Of The Board Meeting Of The Company Held On 04.11.2022 To Consider Financial Statements For The Period Ended September 2022 And Other Business Matters

 Pursuant to Regulation 30 and 33 of SEBI (LODR) Regulations, 2015, We are pleased to inform the Stock Exchange that the Board of Directors at their meeting held today i.e. 04th November, 2022, at 232-B, 3RD Floor, Okhla Industrial Estate, Phase-III, New Delhi - 110020, approved the following businesses: a) Unaudited Financial Results (Consolidate & Standalone) for the Second quarter and half year ended on 30th September 2022. b) Any Other Item.
04-11-2022
Bigul

POLY MEDICURE LTD. - 531768 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that an earnings call will be held on Monday, 7th November, 2022 at 4.00 p.m. (IST) for discussing the Un-audited Financial Results of the Company for the quarter ended 30th September, 2022. Link for joining, Dial in and other details of the call are enclosed herewith. ICICI Securities Limited through its representatives along with Company's officials will coordinate the aforesaid meeting.
03-11-2022
Bigul

POLY MEDICURE LTD. - 531768 - Board Meeting Intimation for Notice Of Board Meeting To Be Held On 4Th November, 2022

 POLY MEDICURE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2022 ,inter alia, to consider and approve Pursuant to Regulation 29(1) of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015, notice is hereby given that a meeting of the Board of Directors of the Company will be held on Friday, the 4th November, 2022, inter alia to consider the following: a) To consider and approve the Standalone and Consolidated Un-Audited Financial Results of the Company for the Second quarter and half year ended on 30th September, 2022. b) To transact any other matter which the Board may deem fit.
19-10-2022
Bigul

POLY MEDICURE LTD. - 531768 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 In terms of Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, we enclose herewith confirmation certificate received from M/s Mas Services Limited, Registrar & Share Transfer Agent of the Company for the quarter ended 30th September, 2022. Request to take the same in your records and oblige.
11-10-2022
Bigul

POLY MEDICURE LTD. - 531768 - Closure of Trading Window

 It may please be noted that in compliance with the SEBI (Prohibition to Insider Trading) Regulations, 2015 as amended by the SEBI (Prohibition of Insider Trading) (Amendment) Regulations, 2018 read with clarification given by BSE Circular Ref No.: LIST/COMP/01/2019-20 dated 02.04.2019 and NSE letter ref no: NSE/CML/2019/11 dated 02.04.2019 read with Company''s Code of Conduct for prevention of Insider Trading, the Trading Window of the Company has been kept closed for designated person from Saturday, the 1st October, 2022 till the end of 48 hours after the declaration of Financial Results for the quarter and half-year ended on 30th September, 2022
30-09-2022
Bigul

POLY MEDICURE LTD. - 531768 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

 Voting results of the 27th Annual General Meeting pursuant to Regulation 44(3) of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 along with Scrutinizer's Report. Pursuant to regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are submitting herewith the details of voting results in the prescribed format of the items/businesses transacted at the 27th Annual General Meeting of the Company held on Monday, 26th day of September, 2022 at 10.00 a.m. through Video Conferencing (VC) / Other Audio Visual Means (OAVM).
28-09-2022
Bigul

POLY MEDICURE LTD. - 531768 - Shareholder Meeting / Postal Ballot-Outcome of AGM

 Pursuant to provisions of Regulation 30 read with Para A of Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("SEBI Listing Regulations"), we wish to submit summary of proceedings of the 27th Annual General Meeting of the Company held on 26th September, 2022, through Video Conferencing ('VC')/Other Audio Visual Means ('OAVM'). Further, the detailed results of remote e-voting and the e-voting conducted at the time of AGM on all the businesses as set out in the Notice, as required under Regulation 44 of the SEBI Listing Regulations shall be forwarded to you on the receipt of Scrutinizer''s Report.
26-09-2022
Bigul

POLY MEDICURE LTD. - 531768 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Pursuant to Regulation 30 and 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the "SEBI Listing Regulations") read with the General Circular No. 2/2022 dated 5th May, 2022 issued by the Ministry of Corporate Affairs. We herewith enclosed the newspaper advertisement-published on 4th September, 2022 in Financial Express, English All Edition and Jansatta, Hindi Delhi Edition.
05-09-2022
Next Page
Close

Let's Open Free Demat Account